Agnew, 28, has done her Ph.D. work with a team of researchers — including Caltech chemistry professor James Heath — to help them develop synthetic antibodies called «protein capture agents,» which can identify, bind to and remove protein biomarkers that are indicators of disease and infection. (scientificamerican.com)
In March chemists created a promising alternative: a synthetic antibody that can disable a pathogen in a living animal. (discovermagazine.com)